BNTX vs. VKTX

Last updated Jun 12, 2026

BNTX (BioNTech SE) and VKTX (Viking Therapeutics, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, BNTX returned -17.42%/yr vs 36.31%/yr for VKTX. At a 0.23 correlation, their price movements are largely independent.

Performance

BNTX vs. VKTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in BioNTech SE (BNTX) and Viking Therapeutics, Inc. (VKTX). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, BNTX achieves a -5.95% return, which is significantly higher than VKTX's -18.68% return.

BNTX

• 1D: 3.93%
• 1M: -4.40%
• YTD: -5.95%
• 6M: -6.73%
• 1Y: -15.10%
• 3Y*: -6.57%
• 5Y*: -17.42%
• 10Y*: —

VKTX

• 1D: 3.10%
• 1M: -8.65%
• YTD: -18.68%
• 6M: -23.11%
• 1Y: -1.17%
• 3Y*: 6.42%
• 5Y*: 36.31%
• 10Y*: 36.76%

*Multi-year figures are annualized to reflect compound growth (CAGR)

BNTX vs. VKTX - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
BNTX BioNTech SE	-5.95%	-16.45%	7.97%	-29.74%	-40.40%	216.24%	140.61%	105.33%
VKTX Viking Therapeutics, Inc.	-18.68%	-12.57%	116.23%	97.98%	104.35%	-18.29%	-29.80%	25.80%

Correlation

The correlation between BNTX and VKTX is 0.39, which is low. Their price movements are largely independent, making them effective diversification partners.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	0.39
Correlation (3Y) Calculated over the trailing 3-year period	0.27
Correlation (5Y) Calculated over the trailing 5-year period	0.25
Correlation (All Time) Calculated using the full available price history since Oct 10, 2019	0.23

The correlation between BNTX and VKTX shifts across timeframes, from 0.23 (all time) to 0.39 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap BNTX : $22.64B VKTX : $3.31B
EPS BNTX : -€5.14 VKTX : -$4.16
PB Ratio BNTX : 1.05 VKTX : 6.59
Total Revenue (TTM) BNTX : €2.80B VKTX : $0.00
Gross Profit (TTM) BNTX : €2.05B VKTX : -$208.00K
EBITDA (TTM) BNTX : -€815.04M VKTX : -$501.77M

Return for Risk

BNTX vs. VKTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BNTX

BNTX Risk / Return Rank: 25
BNTX Sharpe Ratio Rank: 27
BNTX Sortino Ratio Rank: 27
BNTX Omega Ratio Rank: 26
BNTX Calmar Ratio Rank: 25
BNTX Martin Ratio Rank: 21

VKTX

VKTX Risk / Return Rank: 44
VKTX Sharpe Ratio Rank: 43
VKTX Sortino Ratio Rank: 45
VKTX Omega Ratio Rank: 48
VKTX Calmar Ratio Rank: 42
VKTX Martin Ratio Rank: 42

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

BNTX vs. VKTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for BioNTech SE (BNTX) and Viking Therapeutics, Inc. (VKTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	BNTX	VKTX	Difference
Sharpe ratio: Return per unit of total volatility	-0.37	-0.02	-0.35
Sortino ratio: Return per unit of downside risk	-0.25	0.52	-0.77
Omega ratio: Gain probability vs. loss probability	0.96	1.08	-0.12
Calmar ratio: Return relative to maximum drawdown	-0.51	-0.03	-0.48
Martin ratio: Return relative to average drawdown	-1.04	-0.05	-0.98

BNTX vs. VKTX - Sharpe Ratio Comparison

The current BNTX Sharpe Ratio is -0.37, which is lower than the VKTX Sharpe Ratio of -0.02. The chart below compares the historical Sharpe Ratios of BNTX and VKTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

BNTX vs. VKTX - Drawdown Comparison

The maximum BNTX drawdown since its inception was -82.08%, smaller than the maximum VKTX drawdown of -90.41%. Use the drawdown chart below to compare losses from any high point for BNTX and VKTX.

Drawdown Indicators

	BNTX	VKTX	Difference
Max Drawdown Largest peak-to-trough decline	-82.08%	-90.41%	+8.33%
Max Drawdown (1Y) Largest decline over 1 year	-29.71%	-45.14%	+15.43%
Max Drawdown (3Y) Largest decline over 3 years	-37.35%	-78.86%	+41.51%
Max Drawdown (5Y) Largest decline over 5 years	-82.08%	-78.86%	-3.22%
Max Drawdown (10Y) Largest decline over 10 years	—	-89.26%	—
Current Drawdown Current decline from peak	-79.52%	-69.72%	-9.80%
Average Drawdown Average peak-to-trough decline	-56.23%	-60.01%	+3.78%
Ulcer Index Depth and duration of drawdowns from previous peaks	14.60%	22.80%	-8.20%

Volatility

BNTX vs. VKTX - Volatility Comparison

The current volatility for BioNTech SE (BNTX) is 9.62%, while Viking Therapeutics, Inc. (VKTX) has a volatility of 15.32%. This indicates that BNTX experiences smaller price fluctuations and is considered to be less risky than VKTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	BNTX	VKTX	Difference
Volatility (1M) Calculated over the trailing 1-month period	9.62%	15.32%	-5.70%
Volatility (6M) Calculated over the trailing 6-month period	34.13%	40.84%	-6.71%
Volatility (1Y) Calculated over the trailing 1-year period	41.12%	74.00%	-32.88%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	55.27%	101.60%	-46.33%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	76.37%	97.02%	-20.65%

Dividends

BNTX vs. VKTX - Dividend Comparison

Neither BNTX nor VKTX has paid dividends to shareholders.

Position	TTM	2025	2024	2023	2022
BNTX BioNTech SE	0.00%	0.00%	0.00%	0.00%	2.43%
VKTX Viking Therapeutics, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%

Financials

Frequently Asked Questions

Can I hold both BNTX and VKTX in my portfolio?

BNTX and VKTX have a correlation of 0.39, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, BNTX or VKTX?

VKTX has higher volatility (15.32%) compared to BNTX (9.62%). In terms of maximum drawdown, BNTX dropped -82.08% vs VKTX's -90.41%.

Which has better risk-adjusted returns?

VKTX currently has the higher Sharpe Ratio (-0.02 vs -0.37), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.